Xiaoxing Luo Selected Research

thanatin

1/2019	The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
1/2016	The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.
10/2013	R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro.
1/2011	Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoxing Luo Research Topics

Disease

14	Infections 04/2022 - 07/2009
5	Sepsis (Septicemia) 01/2020 - 07/2009
4	Brain Ischemia (Cerebral Ischemia) 04/2019 - 04/2015
3	Ischemic Stroke 10/2018 - 04/2015
3	Osteoporosis 01/2017 - 07/2013
3	Lung Injury 04/2009 - 04/2002
2	Stroke (Strokes) 01/2021 - 10/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2012
2	Communicable Diseases (Infectious Diseases) 02/2020 - 01/2016
2	Hemolysis 01/2020 - 01/2011
2	Bacterial Infections (Bacterial Infection) 01/2020 - 06/2010
2	Ischemia 04/2019 - 02/2012
2	Body Weight (Weight, Body) 01/2016 - 07/2013
2	Acute Lung Injury 04/2009 - 04/2002
2	Necrosis 05/2003 - 09/2002
2	Pulmonary Edema 09/2002 - 04/2002
1	Reperfusion Injury 04/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2019
1	Urinary Tract Infections (Urinary Tract Infection) 04/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2016
1	Infarction (Infarctions) 03/2016
1	Metabolic Bone Diseases (Osteopenia) 07/2013
1	Bone Resorption 07/2013
1	Postmenopausal Osteoporosis 07/2013
1	Exophthalmos (Proptosis) 09/2012
1	Hyperthyroidism 09/2012
1	Gram-Negative Bacterial Infections 03/2012
1	Ventricular Fibrillation 02/2012
1	Ventricular Tachycardia 02/2012
1	Cardiac Arrhythmias (Arrythmia) 02/2012
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2008
1	Hemorrhage 01/2007
1	Thrombosis (Thrombus) 01/2007
1	Pulmonary Embolism 01/2007
1	Inflammation (Inflammations) 05/2003
1	Pneumonia (Pneumonitis) 09/2002

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 06/2010
6	Pharmaceutical PreparationsIBA 01/2021 - 06/2010
4	Exenatide (Byetta)FDA Link 01/2021 - 07/2013
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 09/2012
4	thanatinIBA 01/2019 - 01/2011
3	Neuroprotective AgentsIBA 01/2021 - 04/2015
3	Glucagon-Like Peptide-1 ReceptorIBA 04/2016 - 07/2013
2	Antisense OligonucleotidesIBA 04/2022 - 07/2009
2	Proteins (Proteins, Gene)FDA Link 02/2020 - 10/2018
2	Histamine (Histamine Dihydrochloride)FDA Link 02/2012 - 06/2008
2	Interferon-gamma (Interferon, gamma)IBA 05/2003 - 04/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002 - 04/2002
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	OMPA outer membrane proteinsIBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	AdrenomedullinIBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	hydroxysafflor yellow AIBA 04/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2019
1	Histones (Histone)IBA 10/2018
1	Caspase 3 (Caspase-3)IBA 10/2018
1	CoagulaseIBA 01/2017
1	Antisense RNA (Anti-Sense RNA)IBA 01/2016
1	ProdrugsIBA 04/2015
1	Proglucagon (Glucagon Precursors)IBA 04/2015
1	Hemolysin Proteins (Hemolysins)IBA 02/2015
1	Staphylococcus aureus RNAIIIIBA 02/2015
1	LigandsIBA 07/2013
1	OsteoprotegerinIBA 07/2013
1	FluoroquinolonesIBA 03/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2012
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	beta Lactam AntibioticsIBA 07/2009
1	Liposomes (Liposome)IBA 07/2009
1	OligodeoxyribonucleotidesIBA 07/2009
1	5'-N-methylcarboxamideadenosineIBA 07/2009
1	AnionsIBA 07/2009
1	RNA (Ribonucleic Acid)IBA 04/2009
1	Adenosine DeaminaseIBA 04/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2008
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2007
1	CollagenIBA 01/2007
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2007
1	Messenger RNA (mRNA)IBA 05/2003
1	Glutamic Acid (Glutamate)FDA Link 05/2003
1	Inosine FDA Link 05/2003
1	immune RNA (I-RNA)IBA 05/2003
1	Serotonin ReceptorsIBA 05/2003
1	Adenosine (Adenocard)FDA LinkGeneric 05/2003

Therapy/Procedure

4	Therapeutics 04/2022 - 01/2011
2	Catheters 05/2020 - 10/2013
1	Withholding Treatment 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Culture Diffusion Chambers 05/2020
1	Immunomodulation 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019
1	Stents 04/2016
1	Intranasal Administration 03/2016
1	Ovariectomy (Oophorectomy) 07/2013
1	Decompression 09/2012
1	Endoscopes 09/2012
1	Chemical Sympathectomy 02/2012